MetLife Investment Management’s 908 Devices MASS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$150K Buy
17,292
+270
+2% +$2.07K ﹤0.01% 2566
2026
Q1
$104K Buy
17,022
+6,074
+55% +$38K ﹤0.01% 2524
2025
Q4
$57.5K Buy
10,948
+582
+6% +$4.07K ﹤0.01% 2718
2025
Q3
$90.8K Sell
10,366
-7,455
-42% -$49.5K ﹤0.01% 2688
2025
Q2
$127K Buy
+17,821
New +$99K ﹤0.01% 2417
2024
Q3
Sell
-13,430
Closed -$69.2K 2870
2024
Q2
$69.2K Buy
13,430
+1,440
+12% +$8.7K ﹤0.01% 2708
2024
Q1
$90.5K Hold
11,990
﹤0.01% 2581
2023
Q4
$135K Hold
11,990
﹤0.01% 2458
2023
Q3
$79.9K Hold
11,990
﹤0.01% 2700
2023
Q2
$82.3K Hold
11,990
﹤0.01% 2797
2023
Q1
$103K Hold
11,990
﹤0.01% 2541
2022
Q4
$91.4K Hold
11,990
﹤0.01% 2628
2022
Q3
$197K Hold
11,990
﹤0.01% 2312
2022
Q2
$247K Hold
11,990
﹤0.01% 2166
2022
Q1
$228K Buy
11,990
+4,275
+55% +$73.5K ﹤0.01% 2275
2021
Q4
$200K Buy
7,715
+2,570
+50% +$75.6K ﹤0.01% 2053
2021
Q3
$167K Buy
+5,145
New +$175K ﹤0.01% 2198
2021
Q2
Sell
-3,696
Closed -$179K 2462
2021
Q1
$179K Buy
+3,696
New +$211K ﹤0.01% 2113

Other funds holding MASS

MetLife Investment Management's MASS Position: Q2 2026 in Review

MetLife Investment Management increased its 908 Devices (MASS) stake by 1.6% in Q2 2026, buying an estimated $2.07K and bringing the position to 17,292 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #2566.

MetLife Investment Management first reported a position in MASS in Q1 2021 and has held it in 18 quarters since. The position peaked at $247K in Q2 2022. 112 funds tracked by Wall St. Rank hold MASS as of Q2 2026.

  • MetLife Investment Management held 17,292 shares of 908 Devices worth $150K as of Q2 2026.
  • MetLife Investment Management bought 270 908 Devices shares in Q2 2026, an estimated $2.07K.
  • 908 Devices made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2566 holding.
  • MetLife Investment Management first reported a position in 908 Devices in Q1 2021 and has held it in 18 quarters since.
  • MetLife Investment Management's 908 Devices position peaked at $247K in Q2 2022.
  • 112 funds tracked by Wall St. Rank held 908 Devices as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.